COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 2929: Articles 29281-29290  | Next

Bioinformatics Study on Structural Protein of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) For Better Understanding the Vaccine Development
Gulzar, S., Hussain, S.
10.1101/2020.04.21.053199 — Posted: 2020-04-21
Inhibition of PIKfyve kinase prevents infection by EBOV and SARS-CoV-2
Kang, Y.-L., Chou, Y.-Y., Rothlauf, P. W., Liu, Z., Piccinotti, S., Soh, T. K., Cureton, D., Case, J. B., Chen, R. E., Diamond, M. S., Whelan, S. P. J., Kirchhausen, T.
10.1101/2020.04.21.053058 — Posted: 2020-04-21
Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2: toward universal blueprints for vaccine designs
Malone, B., Simovski, B., Moline, C., Cheng, J., Gheorghe, M., Fontenelle, H., Vardaxis, I., Tennoe, S., Malmberg, J.-A., Stratford, R., Clancy, T.
10.1101/2020.04.21.052084 — Posted: 2020-04-21
SARS-CoV-2 Encodes a PPxY Late Domain Motif that is Known to Enhance 1 Budding and Spread in Enveloped RNA Viruses
maaroufi, H.
10.1101/2020.04.20.052217 — Posted: 2020-04-21
No evidence that androgen regulation of pulmonary TMPRSS2 explains sex-discordant COVID-19 outcomes
Baratchian, M., McManus, J., Berk, M., Nakamura, F., Erzurum, S., Mukhopadhyay, S., Drazba, J., Peterson, J., Gaston, B., Sharifi, N.
10.1101/2020.04.21.051201 — Posted: 2020-04-21 Discussion: Onsite
A Scalable, Easy-to-Deploy, Protocol for Cas13-Based Detection of SARS-CoV-2 Genetic Material
Rauch, J. N., Valois, E., Solley, S. C., Braig, F., Lach, R. S., Baxter, N. J., Kosik, K. S., Arias, C., Acosta-Alvear, D., Wilson, M. Z.
10.1101/2020.04.20.052159 — Posted: 2020-04-21 Discussion: Onsite
Enisamium is a small molecule inhibitor of the influenza A virus and SARS-CoV-2 RNA polymerases
Walker, A., Fan, H., Keown, J. R., Margitich, V., Grimes, J. M., Fodor, E., te Velthuis, A. J.
10.1101/2020.04.21.053017 — Posted: 2020-04-21 Discussion: Offsite
Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals
Zhu, Y., Yu, D., Han, Y., Yan, H., Chong, H., Ren, L., Wang, J., Li, T., He, Y.
10.1101/2020.04.20.052126 — Posted: 2020-04-21
Human iPSC-Derived Cardiomyocytes are Susceptible to SARS-CoV-2 Infection
Sharma, A., Garcia, G., Arumugaswami, V., Svendsen, C. N.
10.1101/2020.04.21.051912 — Posted: 2020-04-21
A New Resource for Genomics and Precision Health Information and Publications on the Investigation and Control of COVID-19 and other Coronaviruses
Yu, W., Gwinn, M., Khoury, M. J.
10.1101/2020.04.21.050922 — Posted: 2020-04-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).